#VELA TECHNOLOGIES PLC – PUT OPTION AGREEMENT – COVID-19 application of AZD1656 April 20, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

Put Option for potential sale of Economic Interest in AZD1656 The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, is pleased to announce that the Company has today entered into a put option agreement (“the Option Agreement”) to give the Company the right, but not the obligation (“the Option”), to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for a total…

Continue reading

#VELA Vela Technologies – Update re. #SGSC St George Street Capital COVID-19 trial August 18, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes that St George Street Capital Ltd (“SGSC”), has today announced the publication in Lancet eClinicalMedicine of details of the ARCADIA clinical trial which investigated AZD1656 for people with diabetes and COVID-19.   Vela holds an economic interest in the commercialisation of AZD1656, details of which were included in the announcement published by Vela on 20 October…

Continue reading